Innovative Approaches to Achieve Immediate or Controlled Release Profiles from 3D Printed Dosage Forms
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Pharmaceutical Technology, Manufacturing and Devices".
Deadline for manuscript submissions: closed (30 May 2023) | Viewed by 328
Special Issue Editor
Interests: 3D printing; drug release; drug nanocarriers; personalized medicine; polymers; solid dosage forms
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The use of 3D printing in pharmaceutics has been increasing in the last decade, as a versatile approach to obtain customised drug dosage forms. Research groups around the world have reported different approaches to tailor the drug dose and the drug release profile of 3D printed formulations, which may be administered by diverse routes. Several 3D printing techniques have been proposed, such as fused deposition modelling, direct powder extrusion, semisolid extrusion, stereolithography, digital light processing, and selective laser sintering, among others. Different materials can be used as feedstock, such as resins, polymers, powders, and nanomaterials, depending on the 3D printing technique as well as on the desired properties of the final dosage forms. Therefore, we are looking for current progress and novel approaches to customise 3D printed drug delivery systems using versatile materials and techniques. Contributions will be welcome either as original or review articles. Submissions reporting the overcoming of important challenges in this area are encouraged.
Prof. Dr. Ruy Carlos Ruver Beck
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- additive manufacturing
- characterisation tools
- drug delivery
- drug release
- hydrogels
- implants
- films
- nanocarriers
- nanocrystals
- personalised medicine
- printlets
- polymers
- solid dosage forms
